Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Experimental method for treating mastitis disease by using fagopyrine extract

A technology for disease treatment and experimental methods, applied in the field of medicine, can solve the problems of insufficient alternative treatment drugs and antibiotic residues, and achieve the effects of no antibiotic residues, harmless components, and resistance to resistance.

Inactive Publication Date: 2021-06-18
JILIN UNIV
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] According to the current deficiencies in the treatment of mastitis, the present invention provides an experimental method for the treatment of mastitis with a buckwheat alkali extract. The present invention has medicinal extraction materials that are harmless and have a wide range of sources, and have obvious effects in treating mastitis. It is beneficial to solve the problems of antibiotic residues, the emergence of drug-resistant bacteria and the shortage of alternative therapeutic drugs during the treatment of dairy cow mastitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Experimental method for treating mastitis disease by using fagopyrine extract
  • Experimental method for treating mastitis disease by using fagopyrine extract
  • Experimental method for treating mastitis disease by using fagopyrine extract

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] Combined with the data provided in this patent, the following will give a complete and accurate description of the technical solutions in the embodiments of the present invention. Other embodiments obtained by other skilled persons in this professional field without making breakthrough achievements all belong to the protection category of the present invention.

[0025] S1. Select 8-week-old ICR mice for co-caging, with 1 male and 2 females in each cage. The establishment of the mouse mammary gland inflammation model will be completed within 3 to 7 days after the mice are delivered. The experiment is divided into 3 groups, which are the blank control group (NT), mastitis model group (LPS), drug treatment group (LPS+TBF), 3 mice in each group.

[0026] S2. Mice were given intraperitoneal injection of buckwheat extract once, at a concentration of 10 mg / kg, 0.4 mL per mouse, and the time of administration was 1 hour before LPS injection.

[0027] S3. The mammary gland was...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an experimental method for treating mastitis diseases by using a fagopyridine extract. The fagopyridine extract contains 53.6% of rutin and 37.2% of quercetin. The experimental process is as follows: S1, selecting ICR mice 3-7 days after delivery as experimental subjects in the experiment, dividing the mice into three groups, namely a blank control group (NT), a mastitis model group (LPS) and an administration treatment group (LPS + TBF), and each group comprising three mice; and S2, anesthetizing and fixing the mice by using pentobarbital sodium, injecting LPS into the fourth pair of milk areas of the mice in the mastitis model group and the administration treatment group to construct a mastitis model, and taking a sample after 24 hours. According to the experimental method for treating mastitis by using a fagopyrine extract, the damage condition of the gland tissue is evaluated by using an H&E dyeing technology, and the activity of myeloperoxidase (MPO) in the mammary gland tissue is detected. Experimental results prove that the fagopyrine extract has a treatment effect on mastitis.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to an experimental method for treating mastitis with a buckwheat alkali extract. Background technique [0002] Cow mastitis is an inflammation of the udder parenchyma and interstitium. The etiology is mostly caused by mechanical stimulation, invasion of pathogenic microorganisms and chemical and physical damage. The main symptoms are redness, swelling, heat, pain and other inflammatory manifestations of the breast. At the same time, it is accompanied by symptoms such as reduced or stopped lactation, changes in milk composition, and reduced milk production. The prevention and treatment of dairy cow mastitis causes huge economic losses to animal husbandry every year. [0003] Among the many pathogenic factors causing mastitis, the invasion of pathogenic microorganisms is the main cause. At present, about 150 kinds of pathogens have been found to cause mastitis in cows, among which ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N21/78G01N1/28G01N1/30G01N1/36
CPCG01N21/78G01N1/28G01N1/30G01N1/36
Inventor 付守鹏徐平柳巨雄阚兴池郭文晋陈应生
Owner JILIN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products